Related Experiment Video
Updated: Aug 11, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones
Venugopal Marasanapalle1, Xiaoling Li, Lisa Polin
1Department of Pharmaceutics & Medicinal Chemistry, TJ Long School of Pharmacy & Health Sciences, University of the Pacific, Stockton, CA 95211, USA.
Abstract:
Anticancer drugs have to cross many layers of cells and the extracellular matrix to reach the tumor cells and elicit their pharmacological action. The three dimensional structure (micro-environment) of tumors poses a penetration barrier to antitumor drugs resulting in poor response. Two in vitro model barriers representing the extracellular matrix and multilayered structure of tumors were used in this study to evaluate the permeability of four structurally related antitumor compounds, thioxanthones. Matrigel was used to represent the tumor extracellular matrix and multilayered Caco-2 cells were used to represent the multilayered confluence of solid tumor. The in vitro permeability characteristics of the thioxanthones across the model barriers were correlated to their in vivo distribution. The apparent permeability coefficients of thioxanthone analogs are in the range of 2.9 x 10(-6) to 11.8 x 10(-6) cm/s across matrigel and 12.6 x 10(-6) to 24.5 x 10(-6) cm/s across Caco-2 multilayers. This high in vitro permeability of thioxanthones across the model barriers suggested their good tissue distribution in vivo. Therefore, the use of in vitro model barriers was found to predict in vivo tissue distribution for thioxanthones.
Insights
This study used in vitro models to assess anticancer drug penetration barriers. Thioxanthone compounds showed high permeability, predicting good in vivo tissue distribution for improved tumor targeting.
Area of Science:
- Pharmacology and Drug Delivery
- Cancer Biology
- Biomedical Engineering
Background:
- Tumor micro-environments present penetration barriers to anticancer drugs, limiting efficacy.
- Understanding drug permeability is crucial for effective cancer treatment.
- In vitro models can simulate tumor barriers to predict drug behavior.
Purpose of the Study:
- To evaluate the in vitro permeability of thioxanthone anticancer compounds.
- To correlate in vitro permeability with in vivo drug distribution.
- To validate the use of in vitro models for predicting drug tissue penetration.
Main Methods:
- Utilized two in vitro model barriers: Matrigel for extracellular matrix and Caco-2 cell multilayers for tumor structure.
- Assessed the permeability of four structurally related thioxanthone compounds across these barriers.
- Correlated the measured apparent permeability coefficients with known in vivo distribution data.
Main Results:
- Thioxanthone analogs exhibited apparent permeability coefficients ranging from 2.9 x 10(-6) to 11.8 x 10(-6) cm/s across Matrigel.
- Permeability across Caco-2 multilayers ranged from 12.6 x 10(-6) to 24.5 x 10(-6) cm/s.
- High in vitro permeability correlated with favorable in vivo tissue distribution.
Conclusions:
- In vitro model barriers effectively simulate tumor penetration challenges.
- The permeability of thioxanthones across these models predicts their in vivo distribution.
- This approach offers a valuable tool for optimizing anticancer drug development.
